#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Dermatitis atopic Asthma Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Duchenne muscular dystrophy gene carrier Inclusion body myositis Endometrial cancer Advanced systemic mastocytosis Brain abscess Myxoid liposarcoma Uveitis Aspergillus infection Dedifferentiated liposarcoma Leukocyte adhesion deficiency type I Thymic carcinoma Encephalopathy neonatal Urethral valves Diabetes insipidus Penile cancer More trials…

    Learn about Rare Diseases

    Rhabdomyosarcoma Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Basic Information X-linked lymphoproliferative syndrome – Trials in Disease Netherton’s syndrome – Treatment Anaplastic thyroid cancer – Diagnostics Chondrosarcoma metastatic – Trials in Disease Rhabdomyosarcoma – Life with Disease Idiopathic inflammatory myopathy – Treatment Shprintzen-Goldberg syndrome – Basic Information Myelodysplastic syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Aticaprant TIL CELLS Juniper Berry Oil GSKVX000000017986 LY4170156 Ethanol (96 Per Cent) Pyridoxine Hydrochloride Bp Adrc001 Tofacitinib GSK3862995B Dupilumab Allo-647 HUMAN THROMBIN MB-HUCART19.1 Abc-23B-116 ELTANEXOR Odm-111 Albiglutide Cx-037231 Navitoclax More therapies…

    Learn about Your Condition

    Follicular lymphoma stage IV Lupus nephritis Candida infection Immunosuppression Malignant lymphoid neoplasm Malignant glioma Plasma cell leukaemia Corneal graft rejection Tonsillitis Malignant mast cell neoplasm Skin disorder Cerebral haemorrhage Pyelonephritis Raynaud's phenomenon Colorectal adenocarcinoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of deupsilocin besilate (CYB003) in adults with major depressive disorder comparing two doses against placebo

    Recruiting

    3 1
    Czechia Germany Greece Ireland Poland

  • Study on the Use of 18F-PI-2620 for Patients with Progressive Supranuclear Palsy and Parkinson’s Disease

    Recruiting

    2 1 1
    Investigated Diseases:
    • Progressive supranuclear palsy
    • Parkinson’s disease
    Investigated Drugs:
    • Izaflortaucipir (18F)
    Spain

  • Study of Brenipatide (LY3537031) in Adults with Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

    Recruiting

    2 1
    Investigated Drugs:
    • LY3537031
    Czechia Denmark France Germany Hungary Poland +1

  • Randomized Study of INCB161734 Plus Standard Chemotherapy Drug Combination in Untreated KRAS G12D Metastatic Pancreatic Ductal Adenocarcinoma Patients

    Recruiting

    3 1 1
    Investigated Drugs:
    • Calcium Folinate
    • Fluorouracil
    • Gemcitabine
    Austria Belgium Denmark Finland France Germany +6

  • A Phase III Study of Survodutide in Adults with Compensated NASH Cirrhosis to Assess Liver Outcomes and Safety

    Recruiting

    3 1
    Investigated Diseases:
    • Metabolic dysfunction-associated steatohepatitis
    Investigated Drugs:
    • BI 456906
    • SURVODUTIDE
    Austria Belgium Bulgaria Czechia France Germany +6

  • A Phase III trial of BI 456906 weekly injections in adults with NASH and stage 2‑3 liver fibrosis

    Recruiting

    3 1
    Investigated Diseases:
    • Metabolic dysfunction-associated steatohepatitis
    Investigated Drugs:
    • BI 456906
    • SURVODUTIDE
    Austria Belgium Bulgaria Czechia France Germany +6
1 2 3 … 1,695
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!